Latest Filings

Issuer Activity

Overview :: The Clorox Co (N:CLX) [?]
Business Focus: Household Products Share on StockTwits
Recent Price for CLX
USD 89.13 +0.14 (+0.16%)
NYSE Delayed 15 minutes
Apr 24 1152 EDT
1-Day High 52-Week High P/E 1-Day Volume Mkt Cap ($Mil)
89.53 96.76 20.89 354,005 11,579.24
1-Day Low 52-Week Low Yield Avg. Volume  
88.99 80.20 3.2% 1,139,666  
Log in or sign up for a free account to add this stock to your watch list. During beta also get free PDF company reports for US stocks.

Latest 10 SEC filings (by transaction date) for CLX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 12:04pm ET April 24th, 2014
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Apr 23/14 Apr 21/14 Tataseo Frank A Indirect Ownership Common Stock S - Open market or private sale -126 $90.22
Apr 2/14 Mar 31/14 Harad George J Direct Ownership Deferred Stock Units A - Grant, award or other under Rule 16b-3(d) 327  
Apr 2/14 Mar 31/14 Friedman Tully M Direct Ownership Deferred Stock Units A - Grant, award or other under Rule 16b-3(d) 298  
Mar 31/14 Mar 27/14 Willoughby Dawn C Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -2,950  
Mar 31/14 Mar 27/14 Willoughby Dawn C Direct Ownership Common Stock S - Open market or private sale -2,595 $90.00
Mar 31/14 Mar 27/14 Willoughby Dawn C Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,950 $61.51
Mar 19/14 Mar 17/14 Tataseo Frank A Indirect Ownership Common Stock S - Open market or private sale -970 $88.00
Mar 10/14 Mar 10/14 Loura Ralph E Direct Ownership Stock Option (Right to Buy) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Mar 10/14 Mar 10/14 Loura Ralph E Direct Ownership Stock Option (Right to Buy) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Mar 10/14 Mar 10/14 Loura Ralph E Direct Ownership Stock Option (Right to Buy) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for CLX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 12:04pm ET April 24th, 2014
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Apr 23/14 Apr 21/14 Tataseo Frank A Indirect Ownership Common Stock S - Open market or private sale -126 $90.22
Apr 2/14 Mar 31/14 Harad George J Direct Ownership Deferred Stock Units A - Grant, award or other under Rule 16b-3(d) 327  
Apr 2/14 Feb 14/14 Harad George J Direct Ownership Deferred Stock Units A - Grant, award or other under Rule 16b-3(d) 225  
Apr 2/14 Mar 31/14 Friedman Tully M Direct Ownership Deferred Stock Units A - Grant, award or other under Rule 16b-3(d) 298  
Apr 2/14 Feb 14/14 Friedman Tully M Direct Ownership Deferred Stock Units A - Grant, award or other under Rule 16b-3(d) 370  
Mar 31/14 Mar 27/14 Willoughby Dawn C Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -2,950  
Mar 31/14 Mar 27/14 Willoughby Dawn C Direct Ownership Common Stock S - Open market or private sale -2,595 $90.00
Mar 31/14 Mar 27/14 Willoughby Dawn C Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,950 $61.51
Mar 19/14 Mar 17/14 Tataseo Frank A Indirect Ownership Common Stock S - Open market or private sale -970 $88.00
Mar 10/14 Mar 10/14 Loura Ralph E Direct Ownership Stock Option (Right to Buy) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Sector:  Consumer Non-Cyclicals Industry:  Household Products
 
See Regulatory Filings on SEC
Key People
Donald R. Knauss
Chairman of the Board, Chief Executive Officer
Jacqueline P. Kane
Senior Vice President - Human Resources and Corporate Affairs
Stephen M. Robb
Chief Financial Officer, Senior Vice President
Benno O. Dorer
Chief Operating Officer and Executive Vice President - Cleaning, International and Corporate Strategy
George C. Roeth
Chief Operating Officer and Executive Vice President - Household and Lifestyle
Frank A. Tataseo
Executive Vice President - Professional Products Division, Mergers & Acquisitions, Partnerships and IT
Thomas P. Britanik
Senior Vice President, Chief Marketing Officer
Laura Stein
Senior Vice President, General Counsel
Jon Balousek
Senior Vice President, General Manager - Specialty Division
Dawn Willoughby
Senior Vice President, General Manager - Cleaning Division
   
Company Contact
Address: 1221 Broadway
OAKLAND CA 94612-1888
Tel: 1-510-2717767
Website: www.thecloroxcompany.com
IR: investors.thecloroxcompany.com
Business Overview
The Clorox Company (Clorox) is a manufacturer and marketer of consumer and professional products. Clorox operates in four segments: Cleaning, Household, Lifestyle and International. Clorox sells its products primarily through merchandisers, grocery stores, other retail outlets, distributors and medical supply providers. Clorox markets some of the brand names, including its namesake bleach and cleaning products, Clorox Healthcare, HealthLink, Aplicare and Dispatch products, Green Works naturally derived home care products, Pine-Sol cleaners, Poett home care products, Fresh Step cat litter, Glad bags, wraps and containers, Kingsford charcoal, Hidden Valley and K C Masterpiece dressings and sauces, Brita water-filtration products, and Burt's Bees and gud natural personal care products. During the fiscal year ended June 30, 2012 (fiscal 2012), Clorox acquired HealthLink, Aplicare, Inc., and Soy Vay Enterprises, Inc.
Financial Overview
For the six months ended 31 December 2013, The Clorox Co revenues increased 1% to $2.69B. Net income before extraordinary items decreased 1% to $253M. Revenues reflect Cleaning segment increase from $425M to $911M, Household segment increase from $357M to $724M. Net income was offset by Other Operating Income/Expense decrease of 78% to $2M (income), Advertising costs increase of 2% to $243M (expense).
Employees: 8,400 as of Sep 30, 2013
Reporting Currency: U.S. Dollars
Enterprise value: $13,732M as of Dec 31, 2013
Annual revenue (TTM): $5,654M as of Dec 31, 2013
EBITDA (TTM): $1,149M as of Dec 31, 2013
Net annual income (TTM): $571.00M as of Dec 31, 2013
Free cash flow (TTM): $153.00M as of Dec 31, 2013
Net Debt Last Fiscal Year: $2,171M as of Dec 31, 2013
Shares outstanding: 129,914,045 as of Jan 31, 2014
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization
Competitors with Recent Insider Filings
Church & Dwight Co. (N:CHD)
Newell Rubbermaid (N:NWL)
WD-40 Company (OQ:WDFC)